AST
Asterias Biotherapeutics Inc. Series A
AST
AST
Delisted
AST was delisted on the 7th of March, 2019.
56 hedge funds and large institutions have $18M invested in Asterias Biotherapeutics Inc. Series A in 2015 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $69K
Holders
56
Holding in Top 10
1
Calls
–
Puts
$69K
Top Buyers
1 | +$1.04M | |
2 | +$290K | |
3 | +$269K | |
4 |
State Street
Boston,
Massachusetts
|
+$258K |
5 |
VKH
Virtu KCG Holdings
New York
|
+$75K |
Top Sellers
1 | -$194K | |
2 | -$171K | |
3 | -$108K | |
4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$91K |
5 |
Jane Street
New York
|
-$62K |